The TSEC, ‘Duavive’, has been revealed…“Its strong point is safety”

The new menopausal symptom treatment uncovered its veil. Pfizer has launched the menopausal symptom treatment ‘Duavive’.

Duaviveattractedattention through the TSEC (tissue selective estrogen complex) combining ‘bazedoxifene (BZA)’ and ‘conjugated estrogen (CE)’.

Duavive, which acquired a sale approval on the last July, has caught attention because of its effectiveness to improve serious vasom...